Geron

Graphic of an open door with the words exit above it
Marketing

Geron losing commercial chief shortly after first FDA approval

Less than 50 days after Geron won approval, the exec who helped form its commercial strategy has announced he is leaving “to pursue other interests.”
Nick Paul Taylor Jul 24, 2024 4:34am
Marathon

FDA signs off on Geron's long-awaited blood cancer drug Rytelo

Jun 7, 2024 12:03pm
Food and Drug Administration

Geron hires a host of commercial, marketing execs

Jan 13, 2023 9:15am